Veracyte, Inc.

Veracyte is a global diagnostics company specializing in developing and commercializing genomic tests that improve patient care. They focus on providing clinicians with actionable insights to inform diagnosis and treatment decisions for various cancers and interstitial lung diseases. Their tests are designed to help patients avoid unnecessary procedures and speed time to appropriate treatment. Veracyte utilizes a multi-pronged approach to test development and market access, including a centralized CLIA lab model in the U.S. and a decentralized IVD model for global expansion.

Veracyte's portfolio of tests include Afirma for thyroid cancer, Decipher for prostate and bladder cancers, Prosigna for breast cancer, and Envisia for interstitial lung disease. They are also developing several new tests, including Percepta Nasal Swab for lung cancer risk assessment, Lymphmark for lymphoma subtyping, and Decipher Kidney for kidney cancer treatment decisions. Veracyte's commitment to innovation and collaboration with clinicians and researchers drives their mission to transform cancer care for patients worldwide.

Veracyte offers a variety of job flexibility options, including remote work and flexible schedules. The company has advertised roles that are fully remote, and some positions offer the option to work from home part-time. This flexibility is emphasized as a benefit for employees who are looking to balance work and personal life, and it allows Veracyte to attract and retain talent from a wider geographic area.

Veracyte offers a comprehensive employee benefits package that includes a variety of health insurance options, paid time off, parental leave, and financial well-being programs. In the US, employees are offered medical, dental, and vision insurance, as well as short- and long-term disability, 401(k) retirement plans, and employee stock purchase plans. Additionally, employees have access to commuter benefits, pet insurance, tuition reimbursement, and on-site gyms. In France, employees are offered supplemental health insurance, global mobility support, on-site nursery, meal vouchers, a competitive time-off policy, and home office equipment. These benefits are designed to support employees' growth and well-being both professionally and personally.

Veracyte is a global diagnostics company committed to transforming cancer care by empowering clinicians with high-value insights to guide and assure patients during pivotal moments in their journey. Through its high-performing diagnostic tests, Veracyte aims to help patients avoid unnecessary procedures, speed time to diagnosis, and ensure access to appropriate treatment for challenging diseases such as thyroid, prostate, breast, bladder, and lung cancers, as well as interstitial lung diseases.

Veracyte promotes a culture that is driven by a strong commitment to improving patient care through innovation and collaboration. They emphasize urgency, compassion, and results-driven work, empowering their employees to tackle challenges and make a meaningful impact on the lives of patients. The company fosters an inclusive environment where diverse backgrounds are represented and employees feel valued and integral to their shared goals.

Veracyte is committed to fostering a diverse and inclusive workplace, believing that different backgrounds and perspectives lead to greater innovation and success. They strive to create an environment where all employees feel valued, respected, and empowered to contribute their unique talents. This commitment is reflected in their efforts to recruit and retain a diverse workforce, provide inclusive training and development opportunities, and promote an equitable culture that values all individuals.